STD Rates in New Hampshire

CDC surveillance data for New Hampshire covering chlamydia, gonorrhea, syphilis, and HIV — with 15-year trends, state rankings, and national comparisons.

Data Year: 2023 Source: CDC STI Surveillance Population: 1,402,054
US map with New Hampshire highlighted, showing a combined STD rate of 242.4 per 100,000
242.4per 100K combined
#49 / 50 states
Combined
242.4
per 100K
49th / 50
Chlamydia
196.6
per 100K • 2,756 cases
-3.1 from 2022
US median: 471.3
Gonorrhea
41.9
per 100K • 588 cases
-11.6 from 2022
US median: 152.2
Syphilis P&S
3.9
per 100K • 55 cases
-26.4 from 2022
US median: 14.8

New Hampshire has one of the lowest STD rates in the country — 49th out of 50 states in 2023, with a combined rate of 242.4 cases per 100,000 people. That's a real distinction. But low overall numbers can obscure what's actually been happening on the ground, and in New Hampshire's case, one disease has been climbing for the better part of two decades in ways the headline ranking doesn't capture.

Chlamydia remains the most commonly diagnosed STD in the state, with 2,756 cases reported in 2023 at a rate of 196.6 per 100,000. That's well below the national median of 471.3 — less than half. The rate has also been gradually declining since peaking around 2017 at 327.1, and it dropped another 3.1% between 2022 and 2023. For a state that already sat far below the national norm, the trend is moving in the right direction.

Gonorrhea is where New Hampshire's story gets more complicated. The rate in 2023 was 41.9 per 100,000 — still well below the national median of 152.2, but more than five times higher than it was in 2008, when it sat at just 7.6. That's a 451% increase over 15 years. The rate did pull back 11.6% from 2022 to 2023, which is notable, but the long-run trajectory tells a different story than the low ranking suggests. Syphilis followed a similar pattern — it climbed from 1.5 per 100,000 in 2008 to a peak of 5.3 in both 2021 and 2022 before falling to 3.9 in 2023, still more than two and a half times where it started. Both diseases are well below national medians, but neither has been standing still.

New Hampshire's HIV numbers are among the lowest in the country. Between 2017 and 2022 — the most recent years with available data — new diagnoses ranged from 28 to 38 cases per year, with a rate that never exceeded 3.2 per 100,000. The 2022 figure of 28 cases represents a multi-year low, though some of the apparent decline around 2020 likely reflects pandemic-related disruptions to testing rather than a true drop in transmission. If you're in Manchester, Nashua, or Concord and haven't been tested recently, STDTest.com can help you find a location nearby.

STD Trends in New Hampshire

Chlamydia
196.6
per 100,000 • 2,756 cases
-3.1 from 2022
23.1 since 2008

New Hampshire's chlamydia rate has been declining slowly since a peak of 327.1 per 100,000 in 2017, landing at 196.6 in 2023 — less than half the national median of 471.3. The long-run picture is more nuanced: the rate is still 23% higher than it was in 2008, meaning the current decline is more of a plateau than a reversal. The state remains one of the lowest in the country, but the downward trend has been gradual rather than sharp.

Gonorrhea
41.9
per 100,000 • 588 cases
-11.6 from 2022
451.3 since 2008

Gonorrhea has been the most striking trend in New Hampshire's STD data over the past 15 years — rising 451% from a rate of 7.6 per 100,000 in 2008 to 41.9 in 2023. Even with an 11.6% drop between 2022 and 2023, the rate is more than five times its baseline. New Hampshire still sits well below the national median of 152.2, but the trajectory over this period is one of the steepest in the state's recent public health history.

Syphilis (P&S)
3.9
per 100,000 • 55 cases
-26.4 from 2022
160 since 2008

Syphilis in New Hampshire peaked at 5.3 per 100,000 in both 2021 and 2022, then fell 26.4% to 3.9 in 2023 — the sharpest single-year drop of any STD in the state's recent data. That rate is still more than double where it was in 2008, and it remains below the national median of 14.8 by a wide margin. Whether the 2023 decline marks a turning point or a temporary dip is worth watching.

HIV
2.3
per 100,000 • 28 cases

New Hampshire's HIV data covers 2017 through 2022 and shows a consistently low rate — ranging from 2.3 to 3.2 new diagnoses per 100,000 per year across that period. Case counts held steady around 31 to 38 annually before dipping to 28 in 2022. The apparent decline around 2020 should be read carefully: pandemic-era disruptions to testing likely suppressed diagnosis counts that year, meaning the drop may not reflect a true reduction in transmission.

Know your status — get tested today

Same-day testing at 4,500+ locations. No appointment needed. Results in 1–3 days.

New Hampshire vs National Average

Comparing 2023 rates against the U.S. median across all 50 states.

InfectionNew HampshireUS MedianDifference
Chlamydia196.6471.358.3% below
Gonorrhea41.9152.272.5% below
Syphilis (P&S)3.914.873.6% below

What the numbers mean — and what to do about them

New Hampshire's combined STD rate of 242.4 per 100,000 puts it near the bottom of all U.S. states — 49th out of 50 — and about 62% below the national median. In real terms, that's roughly 3,400 new chlamydia, gonorrhea, and syphilis diagnoses across a state of 1.4 million people in a single year. For most residents, the personal risk on any given day is relatively low. But low statewide rates don't mean zero risk, and they tend to discourage the routine testing that catches infections before they spread.

The number that most warrants attention is gonorrhea. Its rate has risen more than 450% since 2008 — not because of any single outbreak, but through sustained, year-over-year growth. That pattern matters clinically because gonorrhea is frequently asymptomatic, especially in women. People carry it, transmit it, and often have no idea. The same is true for chlamydia, which still accounts for the majority of New Hampshire's STD cases. When symptoms don't appear, testing becomes the only reliable detection method — which is why trends in a low-rate state like New Hampshire can still carry real consequences for untested individuals.

If you live in or near Manchester, Nashua, or Concord, getting tested is straightforward — most clinics offer same-day appointments and results within a few days. New Hampshire's gonorrhea rate has climbed more than 450% over 15 years without most residents noticing. STDTest.com can show you where to get tested today.

WHO SHOULD GET TESTED

Sexually active adults under 25, who account for the majority of chlamydia cases nationally and in New Hampshire. Anyone with multiple partners should also consider routine gonorrhea screening — the state's gonorrhea rate has risen sharply over 15 years, and the infection is often asymptomatic. Men who have sex with men face elevated risk across all three major STDs and should test regularly regardless of symptom status.

HOW OFTEN

Once a year is a reasonable minimum for most sexually active adults. Given that New Hampshire's gonorrhea rate has climbed steadily since 2008 and only recently began to dip, those with new or multiple partners should consider testing every three to six months. Annual testing for chlamydia is recommended for all sexually active women under 25, regardless of the state's comparatively low overall rate.

WHAT TO EXPECT

STD testing is quick and mostly non-invasive. Chlamydia and gonorrhea are typically detected through a urine sample or swab, syphilis through a blood draw, and HIV through a blood test or oral swab. Results usually come back within a few days. Most clinics in Manchester, Nashua, and Concord offer confidential testing, and many accept insurance or offer low-cost options for the uninsured.

Find a clinic near you

4,500+ testing locations nationwide. 100% confidential. Most insurance accepted.

FAQs

New Hampshire's gonorrhea rate climbed from 7.6 per 100,000 in 2008 to 41.9 in 2023 — a 451% increase over 15 years. This mirrors a national trend of rising gonorrhea rates, driven by factors including antibiotic resistance, changes in sexual behavior, and gaps in routine screening. The rate remains well below the national median of 152.2, but the long-run trajectory is one of the most notable shifts in the state's STD data.
New Hampshire ranked 49th out of 50 states in 2023 for combined STD rates, with a combined rate of 242.4 per 100,000 — roughly 62% below the national combined median. Chlamydia came in at 196.6 per 100,000, compared to a national median of 471.3, and gonorrhea at 41.9 versus a national median of 152.2. By most measures, New Hampshire has one of the lowest STD burdens in the country.
Yes — all three major STDs declined from 2022 to 2023. Syphilis fell the most sharply, dropping 26.4% from a rate of 5.3 to 3.9 per 100,000. Gonorrhea dropped 11.6%, from 47.4 to 41.9, and chlamydia fell 3.1%, from 202.8 to 196.6. It was the first year in recent history where all three moved downward simultaneously.
Testing locations are available across New Hampshire's largest cities, including Manchester, Nashua, and Concord. STDTest.com lets you search by zip code to find nearby clinics, urgent care centers, and public health testing sites. Most offer same-day or next-day appointments for standard STD panels.
Annual testing is a reasonable baseline for most sexually active adults, even in a low-rate state like New Hampshire — where a combined rate of 242.4 per 100,000 still translates to nearly 3,400 new diagnoses in a single year. Gonorrhea and chlamydia are frequently asymptomatic, meaning people can carry and transmit them without knowing. Anyone with multiple partners or inconsistent condom use should consider testing every three to six months.
Data sourced from the CDC's annual STI Surveillance Report. Rates are per 100,000 population and reflect reported cases only — actual prevalence is likely higher due to undiagnosed infections. While we strive for accuracy, STDTest.com makes no representations or warranties regarding the completeness or accuracy of this data and is not responsible for any errors or omissions. This page is for informational purposes only and does not constitute medical advice.